Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 2/20 | 1.00 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.48 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.48 |
| ▸ | SLC1A1 | P43005 | 2/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | LAP3 | P28838 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | FAP | Q12884 | 1/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.41 |
| ▸ | DPP7 | Q9UHL4 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
| ▸ | SLCO1B1 | Q9Y6L6 | 1/20 | 0.39 |
| ▸ | GABRP | O00591 | 4/20 | 0.38 |
| ▸ | GABRD | O14764 | 4/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.38 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.38 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.38 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.38 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Valine SCHEMBL29523401 | 1.00 | — | — | |
| Valine SCHEMBL1813972 | 1.00 | SLC7A5 (1.00) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| Valine SCHEMBL29828716 | 1.00 | — | — | |
| Valine SCHEMBL2785563 | 1.00 | SLC7A5 (1.00) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| Valine SCHEMBL43678 | 1.00 | — | — | |
| Valine SCHEMBL8515 | 1.00 | — | — | |
| Valine SCHEMBL31618928 | 1.00 | — | — | |
| Valine SCHEMBL288203 | 1.00 | SLC7A5 (1.00) | SLC7A5SLC1A3SLC1A2SLC1A1TP53 | |
| Valine SCHEMBL8516 | 1.00 | — | — | |
| Valine SCHEMBL29622105 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1694 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144858-A1 | TRUNCATED RESPIRATORY SYNCYTIAL VIRUS F PROTEIN AND USE THEREOF | XIAMEN UNIVERSITY (CN) | 2026-05-28 | — | — | US | claimed |
| US-20250382386-A1 | ANTI-ALK-1 ANTIBODY AND USE THEREOF | KINTOR PHARMACEUTICAL (GUANGDONG) CO., LTD (CN) | 2025-12-18 | — | — | US | claimed |
| EP-4653466-A1 | ANTI-ALK-1 ANTIBODY AND USE THEREOF | KINTOR PHARMACEUTICAL (GUANGDONG) CO., LTD (CN) | 2025-11-26 | — | — | EP | claimed |
| EP-4606823-A1 | SYNTHETIC T CELL RECEPTOR ANTIGEN RECEPTOR SPECIFICALLY BINDING TO LILRB4 AND USE THEREOF | Bristar Immunotech Limited (CN) | 2025-08-27 | — | — | EP | claimed |
| EP-4588942-A1 | TRUNCATED RESPIRATORY SYNCYTIAL VIRUS F PROTEIN AND USE THEREOF | Xiamen University (CN) | 2025-07-23 | — | — | EP | claimed |
| EP-3655529-B1 | NEW MUTATED PTE ENZYMES | LA FOND MEDITERRANEE INFECTION (FR) | 2025-06-25 | — | — | EP | claimed |
| CN-120129690-A | Dual receptor targeted radioligands and uses thereof | 辐联科技香港有限公司 | 2025-06-10 | — | — | CN | claimed |
| CN-120026014-A | Threonine aldolase mutant with improved enzyme activity and application thereof in L-serine production | 中国科学院天津工业生物技术研究所 | 2025-05-23 | — | — | CN | claimed |
| CN-119816525-A | Micelle composed of amphiphilic peptide and antigen carrier nanoparticle using micelle | 润泰佰有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-119639715-A | Nicotinamide mononucleotide adenyltransferase mutant and application thereof | 浙江工业大学 | 2025-03-18 | — | — | CN | claimed |
| US-8372618-B2 | Mutated hyperthermophilic phosphotriesterases and their uses | UNIVERSITE HENRI POINCARE NANCY 1 (FR) | 2013-02-12 | — | — | US | claimed |
| EP-2217619-B1 | CYCLIC, CYSTEIN-FREE PROTEIN | APEPTICO FORSCHUNG & ENTWICKLUNG GMBH (AT) | 2012-11-07 | — | — | EP | claimed |
| US-20110105414-A1 | CYCLIC, CYSTEIN-FREE PROTEIN | APEPTICO FORSCHUNG UND ENTWICKLUNG GMBH (AT) | 2011-05-05 | — | — | US | claimed |
| US-20100333221-A1 | MUTATED HYPERTHERMOPHILIC PHOSPHOTRIESTERASES AND USES THEREOF | UNIVERSITE HENRI POINCARE NANCY 1 (FR) | 2010-12-30 | — | — | US | claimed |
| EP-2142644-A2 | MUTATED HYPERTHERMOPHILIC PHOSPHOTRIESTERASES AND USES THEREOF | Université Henri Poincaré - Nancy 1 (FR) | 2010-01-13 | — | — | EP | claimed |
| WO-2008145865-A2 | MUTATED HYPERTHERMOPHILIC PHOSPHOTRIESTERASES AND USES THEREOF | UNIVERSITE HENRI POINCARE NANCY 1 (FR) | 2008-12-04 | — | — | WO | claimed |
| US-20070196884-A1 | Method For The Detection Of Coliforms And In Particular Escherichia Coli | ISRIM S. CONS. A.R.L. (IT) | 2007-08-23 | — | — | US | claimed |
| EP-1649043-A1 | METHOD FOR THE DETECTION OF COLIFORMS AND IN PARTICULAR ESCHERICHIA COLI | Isrim S.C.a.r.l. (IT) | 2006-04-26 | — | — | EP | claimed |
| US-20050220812-A1 | Screening process | SECRETARY OF STATE FOR DEFENCE, THE (GB) | 2005-10-06 | — | — | US | claimed |
| WO-2005012555-A1 | METHOD FOR THE DETECTION OF COLIFORMS AND IN PARTICULAR ESCHERICHIA COLI | ISRIM S. CONS. A.R.L. (IT) | 2005-02-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260144858-A1 | TRUNCATED RESPIRATORY SYNCYTIAL VIRUS F PROTEIN AND USE THEREOF | FURIN, UPF1, SARS1 | SLC7A5 2307/4885SLC1A3 3077/4885SLC1A2 4387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.